Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a revision tag changing from v3.5.2 to v3.5.3, indicating a small administrative update to the ClinicalTrials.gov record.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check38 days agoChange DetectedHb SS disease added under Resources and Genetic and Rare Diseases Information Center listed as a Resources reference.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1, indicating a minor version update in the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.